Oral semaglutide is currently approved under the brand name Rybelsus ® as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Based on these findings, ...

Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for ...

USA: The recent analysis from the VICTORIA trial has highlighted the potential benefits of vericiguat in managing ...

A new, reassuring study finds that men can take the diabetes drug metformin without worrying that their offspring will suffer ...

On Monday, Novo Nordisk A/S (NYSE:NVO) released the headline results from the SOUL Phase 3 cardiovascular outcomes trial.

Potential fathers with type 2 diabetes can be reassured that taking the drug metformin is not associated with birth defects in their offspring, concludes a large study of more than 3 million ...

Some 61 million people live with diabetes in Europe, of whom about 90% have type 2 diabetes (T2D) [1], in which the body may ...

USA: A recent narrative review has highlighted the effectiveness of GLP-1 receptor agonists (RAs) in treating type 2 diabetes ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

As global populations age, the prevalence of type 2 diabetes and its associated complications, such as sarcopenia, continues to rise.

The findings, based on more than 3 million pregnancies and published by The BMJ, showed that metformin can continue to be ...

According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the ...